Surgical Oncologists and the COVID-19 Pandemic: Guiding Cancer Patients Effectively through Turbulence and Change.
Betacoronavirus
/ pathogenicity
COVID-19
Coronavirus Infections
/ complications
Humans
Infection Control
Neoplasms
/ complications
Pandemics
Patient Education as Topic
Pneumonia, Viral
/ complications
Population Health
Practice Guidelines as Topic
/ standards
SARS-CoV-2
Surgical Oncology
/ standards
Journal
Annals of surgical oncology
ISSN: 1534-4681
Titre abrégé: Ann Surg Oncol
Pays: United States
ID NLM: 9420840
Informations de publication
Date de publication:
Aug 2020
Aug 2020
Historique:
received:
17
05
2020
pubmed:
15
6
2020
medline:
23
7
2020
entrez:
15
6
2020
Statut:
ppublish
Résumé
The COVID-19 pandemic has posed extraordinary demands from patients, providers, and health care systems. Despite this, surgical oncologists must maintain focus on providing high-quality, empathetic care for the almost 2 million patients nationally who will be diagnosed with operable cancer this year. The focus of hospitals is transitioning from initial COVID-19 preparedness activities to a more sustained approach to cancer care. Editorial Board members provided observations of the implications of the pandemic on providing care to surgical oncology patients. Strategies are presented that have allowed institutions to successfully prepare for cancer care during COVID-19, as well as other strategies that will help hospitals and surgical oncologists manage anticipated challenges in the near term. Perspectives are provided on: (1) maintaining a safe environment for surgical oncology care; (2) redirecting the multidisciplinary model to guide surgical decisions; (3) harnessing telemedicine to accommodate requisite physical distancing; (4) understanding interactions between SARS CoV-2 and cancer therapy; (5) considering the ethical impact of professional guidelines for surgery prioritization; and (6) advocating for our patients who require oncologic surgery in the midst of the COVID-19 pandemic. Until an effective vaccine becomes available for widespread use, it is imperative that surgical oncologists remain focused on providing optimal care for our cancer patients while managing the demands that the COVID-19 pandemic will continue to impose on all of us.
Sections du résumé
BACKGROUND
BACKGROUND
The COVID-19 pandemic has posed extraordinary demands from patients, providers, and health care systems. Despite this, surgical oncologists must maintain focus on providing high-quality, empathetic care for the almost 2 million patients nationally who will be diagnosed with operable cancer this year. The focus of hospitals is transitioning from initial COVID-19 preparedness activities to a more sustained approach to cancer care.
METHODS
METHODS
Editorial Board members provided observations of the implications of the pandemic on providing care to surgical oncology patients.
RESULTS
RESULTS
Strategies are presented that have allowed institutions to successfully prepare for cancer care during COVID-19, as well as other strategies that will help hospitals and surgical oncologists manage anticipated challenges in the near term. Perspectives are provided on: (1) maintaining a safe environment for surgical oncology care; (2) redirecting the multidisciplinary model to guide surgical decisions; (3) harnessing telemedicine to accommodate requisite physical distancing; (4) understanding interactions between SARS CoV-2 and cancer therapy; (5) considering the ethical impact of professional guidelines for surgery prioritization; and (6) advocating for our patients who require oncologic surgery in the midst of the COVID-19 pandemic.
CONCLUSIONS
CONCLUSIONS
Until an effective vaccine becomes available for widespread use, it is imperative that surgical oncologists remain focused on providing optimal care for our cancer patients while managing the demands that the COVID-19 pandemic will continue to impose on all of us.
Identifiants
pubmed: 32535870
doi: 10.1245/s10434-020-08673-6
pii: 10.1245/s10434-020-08673-6
pmc: PMC7293588
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2600-2613Subventions
Organisme : NCI NIH HHS
ID : P30 CA023108
Pays : United States
Références
National Institutes of Health NCI, Surveillance, Epidemiology, and End Results Program. Cancer stat facts: common cancer sites 2020. Available from: https://seer.cancer.gov/statfacts/html/common.html .
Carolan A. Conversation with the cancer letter. What to expect: oncology’s response to coronavirus in Italy. Cancer Lett. 1919 March 11. 2020.
European Society of Medical Oncology. Cancer patient management during the COVID-19 pandemic 2020. Available from: https://www.esmo.org/guidelines/cancer-patient-management-during-the-covid-19-pandemic .
Lauer SA, Grantz KH, Bi Q, Jones FK, Zheng Q, Meredith HR, et al. The incubation period of coronavirus disease 2019 (COVID-19) from publicly reported confirmed cases: estimation and application. Ann Int. Med. 2020;172:577-582.
pubmed: 32150748
doi: 10.7326/M20-0504
Cook TM. Personal protective equipment during the COVID-19 pandemic—a narrative review. Anaesthesia. 2020.
Hsu T. Where thousands of masks a day are decontaminated to battle the virus. The New York Times. 2020 April 11.
Tate C. Hilton, Marriott donate free hotel rooms for medical workers responding to coronavirus crisis. USA Today. 2020.
American College of Surgeons. COVID-19: elective case triage guidelines for surgical care 2020. Available from: https://www.facs.org/covid-19/clinical-guidance/elective-case .
American Society of Anesthesiologists. COVID-19 FAQs 2020. Available from: https://www.asahq.org/about-asa/governance-and-committees/asa-committees/committee-on-occupational-health/coronavirus/clinical-faqs#gen .
Lai J, Ma S, Wang Y, Cai Z, Hu J, Wei N, et al. Factors associated with mental health outcomes among health care workers exposed to coronavirus disease 2019. JAMA Netw Open. 2020;3(3):e203976.
pubmed: 32202646
pmcid: 32202646
doi: 10.1001/jamanetworkopen.2020.3976
Ueda M, Martins R, Hendrie PC, McDonnell T, Crews JR, Wong TL, et al. Managing cancer care during the COVID-19 pandemic: agility and collaboration toward a common goal. J Natl Compr Cancer Netw. 2020;18(4):1–4.
Akladios C, Azais H, Ballester M, Bendifallah S, Bolze PA, Bourdel N, et al. Recommendations for the surgical management of gynecological cancers during the COVID-19 pandemic—FRANCOGYN group for the CNGOF. J Gynecol Obstet Hum Reprod. 2020. https://doi.org/10.1016/j.jogoh.2020.101729 .
pubmed: 32407899
pmcid: 7118621
doi: 10.1016/j.jogoh.2020.101729
Bartlett DL, Howe JR, Chang G, Crago A, Hogg M, Karakousis G, et al. Management of cancer surgery cases during the COVID-19 pandemic: considerations. Ann Surg Oncol. 2020;27:1717–20.
pubmed: 32270420
doi: 10.1245/s10434-020-08461-2
American College of Surgeons. COVID-19 guidelines for triage of cancer surgery patients 2020. Available from: https://www.facs.org/covid-19/clinical-guidance/elective-case/cancer-surgery .
Thoracic Surgery Outcomes Research Network Inc. COVID-19 guidance for triage of operations for thoracic malignancies: a consensus statement from thoracic surgery outcomes research network. Ann Thorac Surg. 2020. https://doi.org/10.1016/j.athoracsur.2020.03.005 .
pmcid: 7146713
doi: 10.1016/j.athoracsur.2020.03.005
Topf MC, Shenson JA, Holsinger FC, et al. Framework for prioritizing head and neck surgery during the COVID-19 pandemic. Head Neck. 2020;42(6):1159–1167. https://doi.org/10.1002/hed.26184 .
pubmed: 32298036
pmcid: 7262168
doi: 10.1002/hed.26184
Yang S, Cao P, Du P, Wu Z, Zhuang Z, Yang L, et al. Early estimation of the case fatality rate of COVID-19 in mainland China: a data-driven analysis. Ann Transl Med. 2020;8(4):128.
pubmed: 32175421
pmcid: 7049028
doi: 10.21037/atm.2020.02.66
Yu J, Ouyang W, Chua MLK, Xie C. SARS-CoV-2 Transmission in patients with cancer at a tertiary care hospital in Wuhan, China. JAMA Oncol. 2020.
Zhang L, Zhu F, Xie L, Wang C, Wang J, Chen R, et al. Clinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three hospitals within Wuhan, China. Ann Oncol. 2020. https://doi.org/10.1016/j.annonc.2020.03.296 .
pubmed: 32348852
pmcid: 7270947
doi: 10.1016/j.annonc.2020.03.296
Mazzaferro V, Danelli P, Torzilli G, Busset MDD, Virdis M, Sposito C. A combined approach to priorities of surgical oncology during the COVID-19 epidemic. Ann Surg. 2020.
Kane CK, Gillis K. The use of telemedicine by physicians: still the exception rather than the rule. Health Aff (Millwood). 2018;37(12):1923–30.
doi: 10.1377/hlthaff.2018.05077
University of New Mexico Health Science Center ECHO Institute. Project Echo 2020. Available from: https://echo.unm.edu/ .
Asiri A, AlBishi S, AlMadani W, ElMetwally A, Househ M. The use of telemedicine in surgical care: a systematic review. Acta Inform Med. 2018;26(3):201–6.
pubmed: 30515013
pmcid: 6195401
doi: 10.5455/aim.2018.26.201-206
U.S. Food and Drug Administration. FDA Guidance on Conduct of Clinical Trials of Medical Products during COVID-19 Public Health Emergency. 2020. https://www.fda.gov/media/136238/download .
Center for Medicare and Medicaid Services. Medicare telemedicine health care provider fact sheet 2020. Available from: https://www.cms.gov/newsroom/fact-sheets/medicare-telemedicine-health-care-provider-fact-sheet .
Federation of State Medical Boards. States modifying requirements for telehealth in response to COVID-19 2020. Available from: https://www.fsmb.org/siteassets/advocacy/pdf/states-waiving-licensure-requirements-for-telehealth-in-response-to-covid-19.pdf .
Shankar A, Saini D, Roy S, Mosavi Jarrahi A, Chakraborty A, Bharti SJ, et al. Cancer care delivery challenges amidst coronavirus disease—19 (COVID-19) outbreak: specific precautions for cancer patients and cancer care providers to prevent spread. Asian Pac J Cancer Prev. 2020;21(3):569–73.
pubmed: 32212779
doi: 10.31557/APJCP.2020.21.3.569
pmcid: 7437319
Sidaway P. COVID-19 and cancer: what we know so far. Nat Rev Clin Oncol. 2020;17:336.
pubmed: 32265531
doi: 10.1038/s41571-020-0366-2
Xia Y, Jin R, Zhao J, Li W, Shen H. Risk of COVID-19 for patients with cancer. Lancet Oncol. 2020;21(4):e180.
pubmed: 32142622
pmcid: 7130057
doi: 10.1016/S1470-2045(20)30150-9
Bersanelli M. Controversies about COVID-19 and anticancer treatment with immune checkpoint inhibitors. Immunotherapy. 2020;12:269–73
pubmed: 32212881
doi: 10.2217/imt-2020-0067
Shi H, Han X, Jiang N, Cao Y, Alwalid O, Gu J, et al. Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study. Lancet Infect Dis. 2020;20(4):425–34.
pubmed: 7159053
pmcid: 7159053
doi: 10.1016/S1473-3099(20)30086-4
Tian S, Hu W, Niu L, Liu H, Xu H, Xiao SY. Pulmonary pathology of early-phase 2019 novel coronavirus (COVID-19) pneumonia in two patients with lung cancer. J Thorac Oncol. 2020;15(5):700–4.
pubmed: 32114094
pmcid: 7128866
doi: 10.1016/j.jtho.2020.02.010
Yuen E, Fote G, Horwich P, Nguyen SA, Patel R, Davies J, et al. Head and neck cancer care in the COVID-19 pandemic: a brief update. Oral Oncol. 2020;105:104738.
pubmed: 32345570
pmcid: 7177064
doi: 10.1016/j.oraloncology.2020.104738
American Academy of Otolaryngology—Head and Neck Surgery. AAO-HNS Position statement: otolaryngologists and the COVID-19 pandemic 2020; March 23, 2020. Available from: https://www.entnet.org/content/aao-hns-position-statement-otolaryngologists-and-covid-19-pandemic .
Chen Z, King W, Pearcey R, Kerba M, Mackillop WJ. The relationship between waiting time for radiotherapy and clinical outcomes: a systematic review of the literature. Radiother Oncol. 2008;87(1):3–16.
pubmed: 18160158
doi: 10.1016/j.radonc.2007.11.016
Marron JM, Joffe S, Jagsi R, Spence RA, Hlubocky FJ. Ethics and resource scarcity: ASCO recommendations for the oncology community during the COVID-19 pandemic. J Clin Oncol. 2020. https://doi.org/10.1200/JCO.20.00960 .
pubmed: 32343643
doi: 10.1200/JCO.20.00960
Berlinger N, Wynia M, Powel T, Hester M, Milliken A, Fabi R, et al. Ethical framework for health care institutions responding to novel coronavirus SARS-CoV-2 (COVID-19) guidelines for institutional ethics services responding to COVID-19. The Hastings Center [Internet]. 2020. pp. 1–12. Available from: https://www.thehastingscenter.org/ethicalframeworkcovid19/ .
Woolf SH, Grol R, Hutchinson A, Eccles M, Grimshaw J. Clinical guidelines: potential benefits, limitations, and harms of clinical guidelines. BMJ. 1999;318(7182):527–30.
pubmed: 10024268
pmcid: 1114973
doi: 10.1136/bmj.318.7182.527
Liang W, Guan W, Chen R, Wang W, Li J, Xu K, et al. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol. 2020;21(3):335–7.
pubmed: 32066541
pmcid: 7159000
doi: 10.1016/S1470-2045(20)30096-6
Bleicher RJ. Timing and delays in breast cancer evaluation and treatment. Ann Surg Oncol. 2018;25(10):2829–38.
pubmed: 29968031
pmcid: 6123282
doi: 10.1245/s10434-018-6615-2
Grass F, Behm KT, Duchalais E, Crippa J, Spears GM, Harmsen WS, et al. Impact of delay to surgery on survival in stage I-III colon cancer. Eur J Surg Oncol. 2020;46(3):455–61.
pubmed: 31806516
doi: 10.1016/j.ejso.2019.11.513
Kaltenmeier C, Shen C, Medich DS, Geller DA, Bartlett DL, Tsung A, et al. Time to surgery and colon cancer survival in the United States. Ann Surg. 2019. https://doi.org/10.1097/SLA.0000000000003745 .
doi: 10.1097/SLA.0000000000003745